首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Acs Medicinal Chemistry Letters

Acs Medicinal Chemistry Letters杂志,由American Chemical Society出版,于2010年创刊,Monthly,出版语言English,ISSN:1948-5875。

投稿咨询
Acs Medicinal Chemistry Letters
Acs Medicinal Chemistry Letters
Acs Medicinal Chemistry Letters
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.9
CiteScore
5.6
期刊收录
SCI、SCIE

Acs Medicinal Chemistry Letters(中文译名:《Acs 药物化学快报》),ISSN:1948-5875,是American Chemical Society出版的国际性学术期刊,创刊于2010年,以Monthly形式稳定发行,2026年总发文量约248篇。该刊采用非OA开放访问,学科归属为CHEMISTRY, MEDICINAL。该刊是医学、药物化学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.9,2025年期刊CiteScore为5.6,2025年期刊自引率约5.1%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Acs Medicinal Chemistry Letters长期聚焦医学、药物化学及相关产业的技术应用前沿,平均审稿周期一般,3-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药物化学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAItaly、CHINA MAINLAND、England、GERMANY (FED REP GER)、Japan、Spain等为核心发文国家与地区;BRISTOL-MYERS SQUIBBCONSIGLIO NAZIONALE DELLE RICERCHE (CNR)、MERCK & COMPANY、UNIVERSITY OF FLORENCE、GLAXOSMITHKLINE、PENNSYLVANIA COMMONWEALTH SYSTEM OF HIGHER EDUCATION (PCSHE)、UNIVERSITY OF CALIFORNIA SYSTEM等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
CHEMISTRY, MEDICINAL 药物化学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
CHEMISTRY, MEDICINAL 药物化学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
CHEMISTRY, MEDICINAL 药物化学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q2 31 / 72

57.6

学科:CHEMISTRY, MEDICINAL SCIE Q2 26 / 72

64.58

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q2 32 / 72

56.3

学科:CHEMISTRY, MEDICINAL SCIE Q2 21 / 72

71.53


中国学者近期发文

1
Design, Synthesis and Biological Evaluation of Oxadiazole-Biphenyl Derivatives as Small Molecule Inhibitors Targeting PD-1/PD-L1 Immune Checkpoin

Author:Xie, Lingfeng; Zhu, Mingxuan; Zhao, Tong; Pei, Yifeng; Wei, Bo; Zhu, Shilong; Chen, Jiaoru; Zhang, Huibin; Zhou, Jinpei

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2026; Vol. 17, Issue 4, pp. 900-908. DOI: 10.1021/acsmedchemlett.6c00048

2
Serial PNA-Transformer-Based Virtual Screening Identifies Nanomolar DYRK1A Inhibitors for Pancreatic Ductal Adenocarcinom

Author:Zhang, Hongyu; Wang, Ke; Wu, Xiaochuan; Zhou, Rui; Li, Chaofeng; Cai, Xiuyu; Zhuang, Yanyan

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2026; Vol. 17, Issue 3, pp. 695-703. DOI: 10.1021/acsmedchemlett.5c00723

3
Design, Synthesis, Molecular Dynamics Simulations, and Biological Evaluation of PB2 Inhibitors as Anti-Influenza A Virus Agen

Author:Hu, Qibo; Xie, Huiru; Zhang, Qiuhong; Zhu, Lian; Che, Jingjing; Chen, Lixia; Li, Xingzhou

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2026; Vol. 17, Issue 3, pp. 688-694. DOI: 10.1021/acsmedchemlett.5c00719

4
Antibody-Targeted Covalent Inhibitor Conjugate (Ab-TCI) Bridged by an Arsenic-Thiol Bond Enables Double Insurance Targeting of Cancer Cells and Kinase for Effective Cancer Treatmen

Author:Zhao, Xinyue; Zhao, Yang; Fang, Ziyang; Wei, Naijie; Chen, Jianbin; Wang, Qiuquan; Yan, Xiaowen

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2026; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.6c00131

5
Potentiated Tumor Photo-immunotherapy Based on Glutamine Starvation and Interferon Stimulatory DNA-Activated cGAS-STING Pathwa

Author:Zhu, Jinwen; Guo, Zhenzhen; Xia, Renpeng; Miao, Peng

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2026; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.6c00074

6
Recent Advances in GPCR Ligand Discovery Using DNA-Encoded Library Technology: From Affinity Binding to Functional Bias and Allosteric Modulatio

Author:Zhou, Ruolan; Wang, Jiajia; Li, Xiang; An, Yulong

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2026; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.6c00113

7
Design, Synthesis, and Protective Activity against Doxorubicin-Induced Cardiotoxicity of Novel Water-Soluble Small-Molecule GPx Mimic

Author:Yu, Zhenming; Shi, Wenxin; Qian, Zhijie; Mei, Xinning; Huang, Xinhui; Chen, Xi; Wang, Wentao; Zhang, Tianyi; Chen, Xin; Li, Zhiyong; Zheng, Canhui

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2026; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.6c00185

8
Repurposing Ilaprazole as a PP5 TPR Domain Binder with Modulatory Effects on MAPK Signalin

Author:He, Yanyi; Gu, Jinying; Hua, Liwen; Zhai, Daichao; Huang, Qifei; Pei, Jiayue; You, Qidong; Zhang, Qiuyue; Wang, Lei

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2026; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.6c00068

9
Recent Advances in DNA-Encoded Library: High-Throughput Identification of Chemical Inducers of Proximity from Degraders to Non-degrader

Author:An, Yulong; Zhou, Ruolan; Li, Xiang

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2026; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.5c00738

10
Design, Synthesis, and Biological Evaluation of Novel 1H-Imidazo[4,5-g]quinazoline-Based SOS1::KRASG12C Inhibitors in Colorectal Cancer Cell

Author:Huang, Xu; Huang, Jingkun; Hong, Qianqian; Ou, Xianhe; Li, Rui; Zong, Meng; Lu, Tao; Zhu, Yong; Hao, Heng; Wu, Sheng; Cui, Hao

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2026; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.5c00754


在线咨询

Acs Medicinal Chemistry Letters

国际简称:ACS Med. Chem. Lett.参考译名:Acs 药物化学快报

年发文量:248 CiteScore:5.6 是否预警:否 Gold OA文章占比:21.19% 研究类文章占比:95.56%

杂志社联系方式:AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, USA, DC, 20036

Acs Medicinal Chemistry Letters